Trial Profile
Phase 2 study of S-1 for elderly patients with advanced non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2020
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 02 Nov 2020 Status changed from recruiting to completed.
- 17 Oct 2017 Planned End Date changed from 30 Jun 2019 to 30 Sep 2017.
- 12 Oct 2015 Planned End Date changed from 1 Jun 2015 to 30 Jun 2019 as reported by University Hospital Medical Information Network - Japan.